NCT05694780 Sleep Health Care in Pregnancy: A Randomized Controlled Trial
| NCT ID | NCT05694780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Pregnancy Related |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2023-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sleep disturbances are one of the most frequent complaints brought to the healthcare professionals during routine prenatal care visits.The purpose of this study is to develop and evaluate a Sleep Training and Education Program (STEP) for improving sleep and health in women during pregnancy.
Eligibility Criteria
Inclusion Criteria: * During the first trimester of pregnancy * Singleton pregnancies Exclusion Criteria: * Women have pregnancy-related complications * Women have diagnosed a psychiatric or sleep disorder
Contact & Investigator
Shao-Yu Tsai
PRINCIPAL INVESTIGATOR
National Taiwan University
Frequently Asked Questions
Who can join the NCT05694780 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05694780 currently recruiting?
Yes, NCT05694780 is actively recruiting participants. Contact the research team at stsai@ntu.edu.tw for enrollment information.
Where is the NCT05694780 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05694780 clinical trial?
NCT05694780 is sponsored by National Taiwan University Hospital. The principal investigator is Shao-Yu Tsai at National Taiwan University. The trial plans to enroll 300 participants.